Because tesamorelin, a stabilized GHRH analogue, has been previously shown to stimulate GH secretion in a physiological manner [9–10], this study was conducted in patients with type 2 diabetes to assess its potential effects on insulin sensitivity and diabetes control. This evidence concerns the gene INS and type 2 diabetes mellitus.